AR and posterior cortical atrophy: In the same way, recent robust findings show that statins could be useful in the advanced stages of PCa when combined with AR axis-targeted therapies (ARATs) for men with high-risk hormone-sensitive PCa (HSPC) or CRPC after radiotherapy.